Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
daptomycin
Description:
A cyclic lipopeptide antibiotic used to treat serious infections caused by susceptible Gram-positive bacteria.
Primary topic:
Antimicrobial Resistance in Staphylococcus (29%)
Related topics:
Antimicrobial Resistance in Staphylococcus (29%),
Antibiotics Pharmacokinetics and Efficacy (9%),
Infective Endocarditis Diagnosis and Management (7%)
OpenAlex ID:
keywords/daptomycin
Mechanisms of Antimicrobial Resistance in Bacteria
2006
·
Fred C. Tenover
·
The American Journal of Medicine
·
1,686
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
2006
·
Vance G. Fowler
, Helen W. Boucher
, et al.
·
New England Journal of Medicine
·
1,467
PDF
BSAC standardized disc susceptibility testing method (version 7)
2008
·
J. M. Andrews
, for the BSAC Working Party on Susceptibility Testing
·
Journal of Antimicrobial Chemotherapy
·
734
PDF
The Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections
2004
·
R. D. Arbeit
, D. Maki
, et al.
·
Clinical Infectious Diseases
·
689
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
2003
·
Jared A. Silverman
, Nancy G. Perlmutter
, et al.
·
Antimicrobial Agents and Chemotherapy
·
656
Has the era of untreatable infections arrived?
2009
·
D. M. Livermore
·
Journal of Antimicrobial Chemotherapy
·
620
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
2005
·
Judith N. Steenbergen
, Jeff Alder
, et al.
·
Journal of Antimicrobial Chemotherapy
·
561
Infections associated with orthopedic implants
2006
·
Andrej Trampuz
, Andreas F Widmer
·
Current Opinion in Infectious Diseases
·
542
Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact
2005
·
Jared A. Silverman
, Lawrence I. Mortin
, et al.
·
The Journal of Infectious Diseases
·
540
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
2015
·
Christopher Crank
, Tristan O'Driscoll
·
Infection and Drug Resistance
·
507
PDF
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
2016
·
Nicholas J. Barrows
, Rafael K. Campos
, et al.
·
Cell Host & Microbe
·
498
PDF
Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A
2014
·
Kazuya Yamanaka
, Kirk A. Reynolds
, et al.
·
Proceedings of the National Academy of Sciences
·
475
PDF
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
2010
·
Marta Ulldemolins
, Jason A. Roberts
, et al.
·
Clinical Pharmacokinetics
·
468
Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus
2006
·
Lisa Friedman
, Jeff D. Alder
, et al.
·
Antimicrobial Agents and Chemotherapy
·
454
Clinical Management of Staphylococcus aureus Bacteremia
2014
·
Thomas L. Holland
, Christopher Arnold
, et al.
·
JAMA
·
449
Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptides
2006
·
Suzana K. Straus
, Robert E.W. Hancock
·
Biochimica et Biophysica Acta (BBA) - Biomembranes
·
448
PDF
Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin
2006
·
G. L. French
·
Journal of Antimicrobial Chemotherapy
·
442
Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains
2016
·
Anna Müller
, Michaela Wenzel
, et al.
·
Proceedings of the National Academy of Sciences
·
425
PDF
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05
2007
·
G. Steinkraus
, R. White
, et al.
·
Journal of Antimicrobial Chemotherapy
·
420
Natural products to drugs: daptomycin and related lipopeptide antibiotics
2005
·
Richard H. Baltz
, Vivian Miao
, et al.
·
Natural Product Reports
·
393
Management of multidrug-resistant enterococcal infections
2010
·
C.A. Arias
, G.A. Contreras
, et al.
·
Clinical Microbiology and Infection
·
389
In Vivo Pharmacodynamic Activity of Daptomycin
2003
·
Nasia Safdar
, David Andes
, et al.
·
Antimicrobial Agents and Chemotherapy
·
374
Antibiotic penetration into bone and joints: An updated review
2019
·
Abrar K. Thabit
, Dania F. Fatani
, et al.
·
International Journal of Infectious Diseases
·
373
PDF
Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry
2005
·
Vivian Miao
, Marie-Françoise Coëffet-LeGal
, et al.
·
Microbiology
·
369
Complicated skin and soft tissue infection
2010
·
M. S. Dryden
·
Journal of Antimicrobial Chemotherapy
·
367
PDF
Show more works
View as search
Works count:
6,671
Citation count:
121,000
Year
Topic
Type